SU-D-217A-01: A High-Resolution in Vivo Molecular Imaging Technique Based on X- Ray Fluorescence

Medical Physics
Pavel ChtcheprovOtto Zhou

Abstract

Traditional molecular imaging techniques such as PET/SPECT have many limitations, including relatively low spatial resolution, short lifetime of radioisotope probes, limited availability due to reliance on cyclotron, relatively high dose, and lack of effective molecular probes for certain tumor cells. In this work we demonstrate the feasibility of a novel x- ray fluorescence molecular imaging (XFMI) technique using high-power carbon nanotube (CNT) x-ray array technology. The XFMI overcomes some limitations and will be a significant advance in molecular imaging technology for cancer drug development and cancer biology research. A testing chamber was constructed containing two Amptek energy-resolving detectors analyzing a copper collimated fluorescence beam placed opposite each other symmetric about the sample and perpendicular to the primary incoming x-ray beam, also using the copper collimator. Different concentrations of indium trichloride and iodine were tested to determine the minimum detectable concentration (MDC) for each. The MDC for indium was found to be 80 ug/mL and 100 ug/mL for iodine at 50 kVp, 30mAs (5 minutes imaging time). This is on the order of magnitude of the MDCs determined at large synchrotron facilities us...Continue Reading

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.